{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:49:12Z","timestamp":1791586152115,"version":"4.3.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1213\/ane.0000000000008372","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:00:15Z","timestamp":1791583215000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Beta Blockade in Septic Shock\u2014Potential Focus for Future Studies"],"prefix":"10.1213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-7083","authenticated-orcid":false,"given":"Sebastian","family":"Rehberg","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Intensive Care, Emergency Medicine, and Pain Medicine, Medical School and Medical Centre OWL, Campus Bethel, Bielefeld University, Bielefeld, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8659-4257","authenticated-orcid":false,"given":"Duaa O.","family":"Khair","sequence":"additional","affiliation":[{"name":"ACFST3 Anaesthetics, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK"},{"name":"Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Slama","sequence":"additional","affiliation":[{"name":"R\u00e9animation M\u00e9dicale, Medical Intensive Care, DRIME Cluster unit, CHU Amiens-Picardie, Amiens, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Whitehouse","sequence":"additional","affiliation":[{"name":"ACFST3 Anaesthetics, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK"},{"name":"Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jama.2013.278477","article-title":"Effect of heart rate control with Esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.","volume":"310","author":"Morelli","year":"2013","journal-title":"JAMA"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S2213-2600(20)30037-0","article-title":"Efficacy and safety of landiolol, an ultra-short-acting \u03b21-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.","volume":"8","author":"Kakihana","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial.","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","article-title":"Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).","volume":"50","author":"Rehberg","year":"2024","journal-title":"Intensive Care Med"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","article-title":"Mortality in patients with sepsis treated with Esmolol or Landiolol: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.","volume":"167","author":"Sato","year":"2025","journal-title":"Chest"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1097\/CCM.0000000000006604","article-title":"Impact of short-acting beta-blockers on the outcomes of patients with septic shock: a systematic review and meta-analysis.","volume":"53","author":"McChesney","year":"2025","journal-title":"Crit Care Med"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","article-title":"Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.","volume":"2","author":"Calfee","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/thorax-2023-220538","article-title":"Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes.","volume":"79","author":"Antcliffe","year":"2024","journal-title":"Thorax"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40635-024-00708-6","article-title":"The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised Study.","volume":"13","author":"Thomas","year":"2025","journal-title":"Intensive Care Med Exp"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00134-018-5134-8","article-title":"Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates.","volume":"44","author":"de Grooth","year":"2018","journal-title":"Intensive Care Med"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fgene.2018.00560","article-title":"Beta 1, Beta 2 and Beta 3 adrenergic receptor gene polymorphisms in a Southeastern European population.","volume":"9","author":"Katsarou","year":"2018","journal-title":"Front Genet"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.ejhg.5201313","article-title":"Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans.","volume":"13","author":"Belfer","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00008571-200104000-00002","article-title":"Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo.","volume":"11","author":"Xie","year":"2001","journal-title":"Pharmacogenetics"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1074\/jbc.274.18.12670","article-title":"A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.","volume":"274","author":"Mason","year":"1999","journal-title":"J Biol Chem"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"30429","DOI":"10.1074\/jbc.M200681200","article-title":"The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation.","volume":"277","author":"Levin","year":"2002","journal-title":"J Biol Chem"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"115869","DOI":"10.1016\/j.biopha.2023.115869","article-title":"Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.","volume":"169","author":"Casta\u00f1o-Amores","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1097\/CCM.0b013e31825b9509","article-title":"Previous prescription of \u03b2-blockers is associated with reduced mortality among patients hospitalized in intensive care units for sepsis.","volume":"40","author":"Macchia","year":"2012","journal-title":"Crit Care Med"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/bja\/aex231","article-title":"Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days.","volume":"119","author":"Fuchs","year":"2017","journal-title":"Br J Anaesth"},{"key":"R20-20261009","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/cc10085","article-title":"Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study.","volume":"15","author":"Christensen","year":"2011","journal-title":"Crit Care"},{"key":"R21-20261009","doi-asserted-by":"crossref","first-page":"e771","DOI":"10.1161\/CIR.0000000000001328","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines.","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"key":"R22-20261009","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/CCM.0b013e3181c03dfa","article-title":"Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.","volume":"38","author":"Ackland","year":"2010","journal-title":"Crit Care Med"},{"key":"R23-20261009","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/TA.0000000000000113","article-title":"Inhibition of sepsis-induced inflammatory response by \u03b21-adrenergic antagonists.","volume":"76","author":"Ibrahim-Zada","year":"2014","journal-title":"J Trauma Acute Care Surg"},{"key":"R25-20261009","doi-asserted-by":"crossref","first-page":"23871","DOI":"10.1074\/jbc.272.38.23871","article-title":"beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists.","volume":"272","author":"January","year":"1997","journal-title":"J Biol Chem"},{"key":"R26-20261009","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00795359","article-title":"Mechanisms of \u03b2-adrenergic receptor desensitization: from molecular biology to heart failure.","volume":"91","author":"Lohse","year":"1996","journal-title":"Basic Res Cardiol"},{"key":"R27-20261009","doi-asserted-by":"crossref","first-page":"512","DOI":"10.3390\/ijms21020512","article-title":"\u03b2-blockers Reverse Agonist-Induced \u03b22-AR downregulation regardless of their signaling profile.","volume":"21","author":"Maccari","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R28-20261009","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13054-020-03445-w","article-title":"Hemodynamic and anti-inflammatory effects of early esmolol use in hyperkinetic septic shock: a pilot study.","volume":"25","author":"Levy","year":"2021","journal-title":"Crit Care"},{"key":"R29-20261009","doi-asserted-by":"crossref","first-page":"R181","DOI":"10.1186\/cc8167","article-title":"Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial.","volume":"13","author":"Dunser","year":"2009","journal-title":"Crit Care"},{"key":"R30-20261009","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00003246-198710000-00006","article-title":"Serial cardiovascular variables in survivors and Nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.","volume":"15","author":"Parker","year":"1987","journal-title":"Crit Care Med"},{"key":"R31-20261009","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","article-title":"NOREPINEPHRINE: NOT TOO MUCH, TOO LONG.","volume":"44","author":"Martin","year":"2015","journal-title":"Shock"},{"key":"R32-20261009","doi-asserted-by":"crossref","first-page":"639562","DOI":"10.3389\/fcvm.2021.639562","article-title":"\u03b21-blockers enhance Inotropy of endogenous Catecholamines in chronic heart failure.","volume":"8","author":"Feuerstein","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"R33-20261009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1751143714555303","article-title":"Raised cardiac troponin in intensive care patients with sepsis, in the absence of Angiographically documented coronary artery disease: a systematic review.","volume":"16","author":"Zochios","year":"2015","journal-title":"J Intensive Care Soc"},{"key":"R34-20261009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00392-011-0375-3","article-title":"Heart rate as an independent risk factor in patients with multiple organ dysfunction: a prospective, observational study.","volume":"101","author":"Hoke","year":"2012","journal-title":"Clin Res Cardiol"},{"key":"R35-20261009","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40560-023-00678-z","article-title":"Correlation between tissue Doppler-derived left ventricular systolic velocity (S\u2019) and left ventricle ejection fraction in sepsis and septic shock: a retrospective cohort study.","volume":"11","author":"Chawla","year":"2023","journal-title":"J Intensive Care"},{"key":"R36-20261009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12871-023-01983-8","article-title":"Evaluating the effects of Esmolol on cardiac function in patients with Septic cardiomyopathy by Speck-tracking echocardiography-a randomized controlled trial.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Anesthesiol"},{"key":"R37-20261009","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/fcp.12988","article-title":"The role of \u03b2-adrenergic receptors in the regulation of cardiac tolerance to ischemia\/reperfusion. Why do \u03b2-adrenergic receptor agonists and antagonists protect the heart?","volume":"38","author":"Maslov","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"key":"R38-20261009","doi-asserted-by":"crossref","first-page":"14780","DOI":"10.1038\/ncomms14780","article-title":"Neutrophil stunning by metoprolol reduces infarct size.","volume":"8","author":"Garc\u00eda-Prieto","year":"2017","journal-title":"Nat Commun"},{"key":"R39-20261009","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40560-021-00553-9","article-title":"Premorbid \u03b21-selective (but not non-selective) \u03b2-blocker exposure reduces intensive care unit mortality among septic patients.","volume":"9","author":"Kuo","year":"2021","journal-title":"J Intensive Care"},{"key":"R40-20261009","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/SLA.0b013e318265427e","article-title":"Long-term propranolol use in severely burned pediatric patients: a randomized controlled study.","volume":"256","author":"Herndon","year":"2012","journal-title":"Ann Surg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:00:20Z","timestamp":1791583220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000008372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":39,"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000008372","relation":{},"ISSN":["0003-2999","1526-7598"],"issn-type":[{"value":"0003-2999","type":"print"},{"value":"1526-7598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}